SEC Form 4 · accession 0001144204-16-078181
MusclePharm Corp · MSLP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stacey Y Jenkins
Director
Period of report
Jan 22, 2016
Accepted (ET)
Feb 1, 2016 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001415684
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 22, 2016 | A | 9,049 | — | A | 19,412 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were an award under the Issuer's 2015 Equity Incentive Compensation Plan.